MDMA Clinical Trials
8 recruitingDrug
Phase 25Phase 11Not Applicable1Early Phase 11
Showing 1–8 of 8 trials
Recruiting
Early Phase 1
MDMA-assisted Therapy for Fibromyalgia
Fibromyalgia
Spaulding Rehabilitation Hospital20 enrolled1 locationNCT06066853
Recruiting
Phase 2
MDMA in Borderline Personality Disorder
Borderline Personality Disorder
Yale University10 enrolled1 locationNCT06683014
Recruiting
Phase 1
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
Posttraumatic Stress Disorder
Johns Hopkins University40 enrolled1 locationNCT06989957
Recruiting
Phase 2
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder
PTSD
Patricia Suppes30 enrolled1 locationNCT05837845
Recruiting
Phase 2
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other
CancerAdjustment Disorders
Sunstone Medical20 enrolled1 locationNCT05584826
Recruiting
Not Applicable
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
Central Diabetes Insipidus
University Hospital, Basel, Switzerland24 enrolled1 locationNCT06789705
Recruiting
Phase 2
MDMA for AUD/PTSD Comorbidity
Post Traumatic Stress DisorderAlcohol Use Disorder
Carolina L Haass-Koffler18 enrolled1 locationNCT05943665
Recruiting
Phase 2
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
Alcohol Use DisorderPTSDAlcohol Dependence
University of Sydney120 enrolled2 locationsNCT05709353